Latest News about FDA
Recent news which mentions FDA
Regulatory Setback For Applied Therapeutics' Lead Program, FDA Highlights Deficiencies In Clinical Application
November 29, 2024
From Benzinga
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
November 28, 2024
From Benzinga
FDA Approves BridgeBio Pharma's Drug For Rare Heart Disease, Poised To Challenge Pfizer In Lucrative Yet Competitive Market
November 25, 2024
From Benzinga
Kennedy's War On Food Dyes Could Be Coming To Your Breakfast Table
November 22, 2024
From Benzinga
From Benzinga
FDA Greenlights Jazz Pharma's Cancer Drug, A Milestone For Zymework
November 21, 2024
From Benzinga
FDA Approves Cannabis Trial For Veterans With PTSD After Years Of Delays
November 20, 2024
Tickers
NEWS
From Benzinga
FDA Approves UCB's Psoriasis Drug For Expanded Use In Painful Inflammatory Skin Disease
November 20, 2024
From Benzinga
From Benzinga
FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease
November 15, 2024
From Benzinga
FDA Grants Conditional Approval For PTC Therapeutics' Gene Therapy As First Ever With Direct Administration In Brain
November 14, 2024
From Benzinga
From Benzinga
Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease
November 13, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.